Medicare Enrolled
Dr. William Cothern, DO
Dermatology · Fort Worth, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cothern from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cothern?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cothern
Dr. William Cothern is a dermatology specialist in Fort Worth, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cothern performed 6,287 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cothern received a total of $32,130 from 42 pharmaceutical and/or device companies across 1538 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cothern is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 18% volume in TX
$32,130 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,287
Medicare services
Top 18% in TX for dermatology
Not available
Unique patients (not deduplicated)
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,610 | $5 | $23 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,544 | $60 | $297 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
661 | $37 | $223 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
489 | $77 | $378 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
170 | $1 | $24 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
147 | $69 | $369 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
72 | $146 | $683 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
67 | $124 | $562 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
60 | $73 | $420 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
55 | $62 | $338 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
52 | $10 | $47 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
46 | $128 | $641 |
| Destruction of skin growth, 15 or more growths | 35 | $83 | $441 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
33 | $130 | $594 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
32 | $98 | $458 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
28 | $0 | $2 |
| Shaving of skin growth, more than 2.0 cm Removal of a skin growth by shaving the surface with a blade. This procedure is performed on the body, arms, or legs when the growth exceeds 2.0 centimeters. |
27 | $106 | $507 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface of the skin. The procedure is performed on the face, ears, eyelids, nose, lips, or mouth and involves a lesion measuring between 1.1 and 2.0 centimeters. |
24 | $116 | $522 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
20 | $33 | $190 |
| Destruction of cancerous skin growth on face, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 2.1 and 3.0 centimeters in diameter. |
20 | $192 | $806 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 18 | $136 | $627 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | 16 | $155 | $694 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
15 | $82 | $417 |
| Shaving of skin growth on face, 0.6-1.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
13 | $97 | $456 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface. The procedure is performed on the scalp, neck, hands, feet, or genitals and involves a lesion measuring between 1.1 and 2.0 centimeters. |
11 | $84 | $464 |
| Shaving of small skin growth on face or mouth area A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth. |
11 | $90 | $389 |
| Removal of noncancer skin growth, 2.1-3.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The excised tissue measures between 2.1 and 3.0 centimeters in diameter. |
11 | $124 | $658 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$32,130
Total received (2018-2024)
Avg $4,590/year across 7 years
Top 9% in TX for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
1,538
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,101
2023
$4,440
2022
$4,162
2021
$3,816
2020
$3,671
2019
$4,652
2018
$7,288
Payments by company (2024)
ABBVIE INC.
$996
Janssen Biotech, Inc.
$750
GENZYME CORPORATION
$512
Dermavant Sciences, Inc.
$396
Regeneron Healthcare Solutions, Inc.
$324
Lilly USA, LLC
$299
E.R. Squibb & Sons, L.L.C.
$185
SUN PHARMACEUTICAL INDUSTRIES INC.
$152
MAYNE PHARMA COMMERCIAL LLC
$143
Galderma Laboratories, L.P.
$76
Ortho Dermatologics, a division of Bausch Health US, LLC
$58
Novartis Pharmaceuticals Corporation
$56
UCB, Inc.
$55
Amgen Inc.
$34
Almirall LLC
$32
LEO Pharma Inc.
$18
PFIZER INC.
$17
Top 3 companies account for 55.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$6,069
GENZYME CORPORATION
$2,181
AbbVie Inc.
$2,009
ABBVIE INC.
$1,966
Lilly USA, LLC
$1,927
Regeneron Healthcare Solutions, Inc.
$1,634
AbbVie, Inc.
$1,499
Amgen Inc.
$1,488
UCB, Inc.
$1,439
Sun Pharmaceutical Industries Inc.
$1,360
PFIZER INC.
$1,145
Galderma Laboratories, L.P.
$1,041
Mayne Pharma Inc.
$984
Novartis Pharmaceuticals Corporation
$947
MAYNE PHARMA INC.
$861
Ortho Dermatologics, a division of Bausch Health US, LLC
$858
Dermavant Sciences, Inc.
$826
Encore Dermatology Inc.
$824
SUN PHARMACEUTICAL INDUSTRIES INC.
$492
E.R. Squibb & Sons, L.L.C.
$378
Celgene Corporation
$368
LEO Pharma Inc.
$263
MAYNE PHARMA COMMERCIAL LLC
$220
VYNE Pharmaceuticals Inc.
$194
DERMIRA, INC.
$189
Almirall LLC
$178
Arcutis Biotherapeutics, Inc.
$151
Paratek Pharmaceuticals, Inc.
$125
Nabriva Therapeutics, plc
$96
Incyte Corporation
$87
DUSA Pharmaceuticals, Inc.
$42
Promius Pharma LLC
$41
Sandoz Inc.
$38
Aclaris Therapeutics, Inc.
$38
Journey Medical Corporation
$35
Mylan Pharmaceuticals Inc.
$33
Merck Sharp & Dohme Corporation
$22
Janssen Scientific Affairs, LLC
$19
Genentech USA, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
Medtronic, Inc.
$18
PruGen, Inc. Pharmaceuticals
$8
Top 3 companies account for 31.9% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMZEEQ · ARAZLO · Absorica LD · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BRYHALI · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Finacea · HUMIRA · HYRIMOZ · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Klisyri · LEVULAN KERASTICK · NUZYRA · ODOMZO · OLUMIANT · OPZELURA · ORACEA · Odomzo · Otezla · QBREXZA · REMICADE · RHOFADE · RINVOQ · Rituxan · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · Sernivo · Seysara · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRI-LUMA · TRIANEX 0.05% · TRILUMA · Tremfya · VENASEAL · VEREGEN · VTAMA · Winlevi · ZILXI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
70
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT AND WHITE SURGICAL HOSPITAL FORTWORTH
3.5 mi
3.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cothern is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cothern experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Cothern performed 2,610 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cothern receive payments from pharmaceutical companies?
Yes. Dr. Cothern received a total of $32,130 from 42 companies across 1,538 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cothern's costs compare to other dermatologists in Fort Worth?
Dr. Cothern's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cothern) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Fort Worth
Browse dermatologists in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in TX
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in TX
Which TX dermatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology